Drug Licensing & Scouting
In today's competitive biotech and pharmaceutical landscape, finding the right licensing opportunities can make or break your company's growth trajectory. Our strategic drug licensing and scouting services help you identify, evaluate, and pursue the most promising opportunities across EU and CIS markets.
What We Offer
Our comprehensive scouting services cover the entire spectrum of drug licensing opportunities, from early-stage research compounds to late-stage clinical assets. We leverage our extensive network in biotech and pharma to identify opportunities that align with your strategic goals.
Key Services
- Opportunity Identification: Systematic scouting for in-licensing and out-licensing opportunities across EU and CIS markets
- Market Analysis: Deep dive into therapeutic areas, competitive landscape, and market potential
- Target Evaluation: Comprehensive assessment of assets, including scientific merit, regulatory pathway, and commercial viability
- Network Access: Leverage our worldwide connections to access opportunities not publicly available
- Strategic Matching: Connect innovators with generic companies, biosimilar companies with innovators, and service providers with biotech companies
Who Benefits
Our services are particularly valuable for:
- Small biotech companies with limited BD resources seeking licensing opportunities
- Generic companies looking for biosimilar opportunities or innovative compounds
- Biosimilar companies seeking partnerships with innovators
- Companies with promising assets looking for out-licensing partners in EU or CIS markets
- Organizations seeking to expand their portfolio through strategic acquisitions
Our Approach
We understand that each company has unique needs and constraints. That's why we offer flexible engagement models—from per-hour consulting for strategic guidance to commission-based arrangements for successful deal closures. Our insight sales approach means we don't just find opportunities; we help you understand why they matter and how to pursue them effectively.
With deep expertise in both EU and CIS markets, we navigate the regulatory, cultural, and business differences that can make or break international licensing deals. Whether you're a CIS company seeking EU market access or an EU company exploring CIS opportunities, we provide the bridge and expertise you need.